Results 11 to 20 of about 636,107 (305)

HIV treatment as prevention: models, data, and questions--towards evidence-based decision-making. [PDF]

open access: yesPLoS Medicine, 2012
Antiretroviral therapy (ART) for those infected with HIV can prevent onward transmission of infection, but biological efficacy alone is not enough to guide policy decisions about the role of ART in reducing HIV incidence.
HIV Modelling Consortium Treatment as Prevention Editorial Writing Group
doaj   +3 more sources

HIV Prevention in Care and Treatment Settings: Baseline Risk Behaviors among HIV Patients in Kenya, Namibia, and Tanzania. [PDF]

open access: yes, 2013
HIV care and treatment settings provide an opportunity to reach people living with HIV/AIDS (PLHIV) with prevention messages and services. Population-based surveys in sub-Saharan Africa have identified HIV risk behaviors among PLHIV, yet data are limited
A Palepu   +52 more
core   +19 more sources

The time has come to make cervical cancer prevention an essential part of comprehensive sexual and reproductive health services for HIV-positive women in low-income countries. [PDF]

open access: yes, 2015
IntroductionHIV and cervical cancer are intersecting epidemics that disproportionately affect one of the most vulnerable populations in the world: women in low- and middle-income countries (LMICs).
Cohen, Craig R   +3 more
core   +8 more sources

The feasibility of modified HIV and antiretroviral drug testing using self-collected dried blood spots from men who have sex with men

open access: yesBMC Infectious Diseases, 2021
Background In the US, one in six men who have sex with men (MSM) with HIV are unaware of their HIV infection. In certain circumstances, access to HIV testing and viral load (VL) monitoring is challenging.
Wei Luo   +11 more
doaj   +1 more source

E-Cigarette Use Among Persons With Diagnosed HIV in the U.S.

open access: yesAJPM Focus, 2023
Introduction: E-cigarettes emerged in the U.S. market in the late 2000s. In 2017, E-cigarette use among U.S. adults was 2.8%, with higher use among some population groups.
Stacy L. Thorne, PhD, MPH   +5 more
doaj   +1 more source

Pharmacokinetics and efficacy of topical inserts containing tenofovir alafenamide fumarate and elvitegravir administered rectally in macaquesResearch in context

open access: yesEBioMedicine, 2022
Summary: Background: Topical on-demand forms for HIV pre-exposure prophylaxis (PrEP) may be a desirable alternative for people that prefer not to use daily PrEP.
Natalia Makarova   +13 more
doaj   +1 more source

HIV-1 subtype diversity and transmission strain source among men who have sex with men in Guangxi, China

open access: yesScientific Reports, 2021
With the rapid increase in HIV prevalence of men who have sex with men (MSM) in recent years and common human migration and travelling across different provinces in China, MSM are now finding it easier to meet each other, which might contribute to local ...
Yi Chen   +13 more
doaj   +1 more source

Effectively Addressing Human Immunodeficiency Virus Disparities Affecting US Black Women

open access: yesHealth Equity, 2018
Black women have disproportionately higher rates of human immunodeficiency virus (HIV) infection, and low percentages being linked to care and becoming virally suppressed, compared with women of other races/ethnicities.
Erin L.P. Bradley   +4 more
doaj   +1 more source

Can a pill prevent HIV? Negotiating the biomedicalisation of HIV prevention [PDF]

open access: yes, 2015
This article examines how biomedicalisation is encountered, responded to and negotiated within and in relation to new biomedical forms of HIV prevention.
Flowers, Paul   +2 more
core   +2 more sources

HIV treatment for prevention [PDF]

open access: yesJournal of the International AIDS Society, 2011
“No virus, no transmission.” Studies have repeatedly shown that viral load (the quantity of virus present in blood and sexual secretions) is the strongest predictor of HIV transmission during unprotected sex or transmission from infected mother to child.Effective treatment lowers viral load to undetectable levels.
Ambrosioni Czyrko, Juan   +2 more
openaire   +4 more sources

Home - About - Disclaimer - Privacy